Arovella Therapeutics Limited Stock
Stocks
ALA
AU0000182784
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
01:56:23 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.0540 AUD | +1.89% |
|
-8.47% | -41.94% |
| 08-20 | Arovella Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-13 | Charles River Laboratories to Provide Cell Sequencing Services to Arovella Therapeutics | MT |
| Market Cap | 65.28M 45.84M 40.23M 37.99M 34.62M 64.82M 4.39B 455M 176M 2.24B 172M 168M 7.21B | P/E 2025 |
-14.6x | P/E 2026 | -10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 50.93M 35.76M 31.38M 29.64M 27.01M 50.56M 3.43B 355M 137M 1.75B 134M 131M 5.63B | EV / Sales 2025 |
28.4x | EV / Sales 2026 | 17.3x |
| Free-Float |
76.3% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ALA | Delayed | |
Deutsche Boerse AG
| E4NA | Delayed | |
|
Börse Stuttgart
| E4NA | Delayed |
| 1 day | +1.89% | ||
| 1 week | -8.47% | ||
| Current month | -10.00% | ||
| 1 month | -12.90% | ||
| 3 months | -18.18% | ||
| 6 months | -19.40% | ||
| Current year | -41.94% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.12 |
| 3 years | 0.05 | | 0.21 |
| 5 years | 0.02 | | 0.21 |
| 10 years | 0.02 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-05-06 | |
Lachie Mallia
DFI | Director of Finance/CFO | - | 2026-01-21 |
Simon Poon
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Williams
CHM | Chairman | 72 | 2026-05-03 |
Mark Diamond
BRD | Director/Board Member | - | 2026-04-27 |
Michael Thurn
BRD | Director/Board Member | - | 2026-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/24/25 | Exercice | Chairman | 1,157,647 | 0.0966% | ||
| 11/24/25 | Exercice | Chairman | 1,242,353 | 0.1036% | ||
| 11/12/25 | Exercice | Director | 1,013,333 | 0.0845% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.89% | -8.47% | -44.33% | -29.87% | 45.84M | |
| -3.30% | +1.50% | +51.24% | +99.26% | 72.26B | |
| +1.25% | -3.01% | +40.12% | +77.12% | 60.24B | |
| +2.12% | +5.26% | +32.50% | +21.28% | 27.73B | |
| -3.06% | -1.81% | -13.10% | +357.06% | 25.74B | |
| -0.75% | +2.56% | +0.45% | -4.46% | 24.75B | |
| +0.40% | +0.75% | +22.91% | -9.68% | 20.74B | |
| -1.70% | -2.12% | +146.86% | +314.52% | 15.06B | |
| +0.36% | -0.34% | +50.32% | +166.42% | 14.42B | |
| +0.21% | +1.17% | -8.07% | +499.10% | 14.23B | |
| Average | -0.26% | -0.45% | +27.89% | +149.08% | 27.52B | |
| Weighted average by Cap. | -0.77% | +0.31% | +36.30% | +129.09% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.44M 2.42M 2.12M 2M 1.82M 3.42M 232M 23.96M 9.28M 118M 9.07M 8.87M 380M | 3.5M 2.46M 2.16M 2.04M 1.86M 3.47M 235M 24.36M 9.44M 120M 9.22M 9.02M 387M |
| Net income | -7.51M -5.27M -4.63M -4.37M -3.98M -7.46M -505M -52.3M -20.26M -258M -19.8M -19.37M -830M | -6.92M -4.86M -4.26M -4.03M -3.67M -6.87M -466M -48.17M -18.66M -238M -18.24M -17.84M -764M |
| Net Debt | -20.88M -14.66M -12.87M -12.15M -11.07M -20.73M -1.41B -145M -56.32M -718M -55.05M -53.86M -2.31B | -14.35M -10.08M -8.85M -8.35M -7.61M -14.25M -966M -99.97M -38.72M -494M -37.85M -37.03M -1.59B |
Employees
27
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | A$0.0540 | +1.89% | 1,089,420 |
| 26-09-24 | A$0.0530 | -6.19% | 656,665 |
| 26-09-23 | A$0.0565 | -0.88% | 314,076 |
| 26-09-22 | A$0.0570 | -1.72% | 224,036 |
| 26-09-21 | A$0.0580 | -1.69% | 1,788,344 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALA Stock
Select your edition
All financial news and data tailored to specific country editions
